Celltrion is a prominent biopharmaceutical company that specializes in the research, development, manufacturing, and distribution of innovative therapeutics, particularly focusing on biosimilars. The company operates Korea's largest Global R&D Center, which is equipped to handle both biologics and small molecules research. Celltrion has established a robust clinical trial experience, particularly in monoclonal antibody (mAb) biopharmaceuticals, and possesses a strong regulatory affairs capability that facilitates the approval and commercialization of its products. The company is recognized for its advanced production facilities, which include US FDA and European EMA cGMP certified sites, and it boasts a significant production capacity of 250,000 liters, enabling it to manufacture a wide range of biopharmaceutical products.

In addition to its R&D and production capabilities, Celltrion has developed a comprehensive distribution network that spans over 100 countries, making it the largest manufacturer and exporter of biosimilars in Korea. The company’s product pipeline includes several approved biosimilars, such as Remsima® and Truxima®, which target various conditions including rheumatoid arthritis and certain types of cancer. Celltrion's commitment to quality is evident in its state-of-the-art production processes, which encompass cell culture, purification, and fill-and-finish operations, all conducted under stringent quality management systems. This integrated approach positions Celltrion as a one-stop solution provider in the biopharmaceutical industry, dedicated to enhancing patient health and well-being globally.

South Korea

Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products.

For additional information on our guidelines, please visit:  
http://tinyurl.com/bdh9bxs9

Celltrion

Company Details